• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植受者早期移植物丢失相关关键因素存在显著种族差异。

Significant racial differences in the key factors associated with early graft loss in kidney transplant recipients.

作者信息

Taber David J, Douglass Kevin, Srinivas Titte, McGillicuddy John W, Bratton Charles F, Chavin Kenneth D, Baliga Prabhakar K, Egede Leonard E

机构信息

Division of Transplant Surgery, Medical University of South Carolina, Charleston, S.C., USA.

出版信息

Am J Nephrol. 2014;40(1):19-28. doi: 10.1159/000363393. Epub 2014 Jun 25.

DOI:10.1159/000363393
PMID:24969370
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4125570/
Abstract

BACKGROUND

There is continued and significant debate regarding the salient etiologies associated with graft loss and racial disparities in kidney transplant recipients.

METHODS

This was a longitudinal cohort study of all adult kidney transplant recipients, comparing patients with early graft loss (<5 years) to those with graft longevity (surviving graft with at least 5 years of follow-up) across racial cohorts [African-American (AA) and non-AA] to discern risk factors.

RESULTS

524 patients were included, 55% AA, 151 with early graft loss (29%) and 373 with graft longevity (71%). Consistent within both races, early graft loss was significantly associated with disability income [adjusted odds ratio (AOR) 2.2, 95% CI 1.1-4.5], Kidney Donor Risk Index (AOR 3.2, 1.4-7.5), rehospitalization (AOR 2.1, 1.0-4.4) and acute rejection (AOR 4.4, 1.7-11.6). Unique risk factors in AAs included Medicare-only insurance (AOR 8.0, 2.3-28) and BK infection (AOR 5.6, 1.3-25). Unique protective factors in AAs included cardiovascular risk factor control: AAs with a mean systolic blood pressure <150 mm Hg had 80% lower risk of early graft loss (AOR 0.2, 0.1-0.7), while low-density lipoprotein <100 mg/dl (AOR 0.4, 0.2-0.8), triglycerides <150 mg/dl (AOR 0.4, 0.2-1.0) and hemoglobin A1C <7% (AOR 0.2, 0.1-0.6) were also protective against early graft loss in AA, but not in non-AA recipients.

CONCLUSIONS

AA recipients have a number of unique risk factors for early graft loss, suggesting that controlling cardiovascular comorbidities may be an important mechanism to reduce racial disparities in kidney transplantation.

摘要

背景

关于肾移植受者移植物丢失的主要病因以及种族差异,一直存在持续且激烈的争论。

方法

这是一项针对所有成年肾移植受者的纵向队列研究,比较了早期移植物丢失(<5年)的患者与移植物长期存活(随访至少5年且移植物存活)的患者在不同种族队列[非裔美国人(AA)和非AA]中的情况,以识别风险因素。

结果

共纳入524例患者,其中55%为非裔美国人,151例早期移植物丢失(29%),373例移植物长期存活(71%)。在两个种族中,早期移植物丢失均与残疾收入[调整优势比(AOR)2.2,95%置信区间1.1 - 4.5]、肾脏供体风险指数(AOR 3.2,1.4 - 7.5)、再次住院(AOR 2.1,1.0 - 4.4)和急性排斥反应(AOR 4.4,1.7 - 11.6)显著相关。非裔美国人的独特风险因素包括仅参加医疗保险(AOR 8.0,2.3 - 28)和BK感染(AOR 5.6,1.3 - 25)。非裔美国人的独特保护因素包括心血管危险因素控制:平均收缩压<150 mmHg的非裔美国人早期移植物丢失风险降低80%(AOR 0.2,0.1 - 0.7),而低密度脂蛋白<100 mg/dl(AOR 0.4,0.2 - 0.8)、甘油三酯<150 mg/dl(AOR 0.4,0.2 - 1.0)和糖化血红蛋白<7%(AOR 0.2,0.1 - 0.6)对非裔美国人的早期移植物丢失也有保护作用,但对非非裔美国人受者无此作用。

结论

非裔美国受者存在一些导致早期移植物丢失的独特风险因素,这表明控制心血管合并症可能是减少肾移植种族差异的重要机制。

相似文献

1
Significant racial differences in the key factors associated with early graft loss in kidney transplant recipients.肾移植受者早期移植物丢失相关关键因素存在显著种族差异。
Am J Nephrol. 2014;40(1):19-28. doi: 10.1159/000363393. Epub 2014 Jun 25.
2
A Comparative Effectiveness Analysis of Early Steroid Withdrawal in Black Kidney Transplant Recipients.黑人肾移植受者早期激素撤药的疗效比较分析。
Clin J Am Soc Nephrol. 2017 Jan 6;12(1):131-139. doi: 10.2215/CJN.04880516. Epub 2016 Dec 15.
3
Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation.他克莫司谷浓度变异性与非裔美国肾移植患者的差异
Transplantation. 2017 Dec;101(12):2931-2938. doi: 10.1097/TP.0000000000001840.
4
Tacrolimus dose requirements in African-American and Caucasian kidney transplant recipients on mycophenolate and prednisone.接受霉酚酸酯和泼尼松治疗的非裔美国人和白种人肾移植受者的他克莫司剂量需求
Clin Transplant. 2014 Jul;28(7):762-7. doi: 10.1111/ctr.12376. Epub 2014 May 23.
5
The impact of time-varying clinical surrogates on disparities in African-American kidney transplant recipients - a retrospective longitudinal cohort study.时间变化的临床替代指标对非裔美国肾移植受者差异的影响——一项回顾性纵向队列研究。
Transpl Int. 2019 Jan;32(1):84-94. doi: 10.1111/tri.13338. Epub 2018 Sep 16.
6
Long-term outcomes in African American kidney transplant recipients under contemporary immunosuppression: a four-yr analysis of the Mycophenolic acid Observational REnal transplant (MORE) study.当代免疫抑制下非裔美国肾移植受者的长期结局:麦考酚酸观察性肾移植(MORE)研究的四年分析。
Clin Transplant. 2014 Feb;28(2):184-91. doi: 10.1111/ctr.12294. Epub 2013 Dec 24.
7
The risk of acute rejection and the influence of induction agents in lower-risk African American kidney transplant recipients receiving modern immunosuppression.接受现代免疫抑制治疗的低风险非裔美国肾移植受者发生急性排斥反应的风险及诱导剂的影响。
Clin Transplant. 2014 Mar;28(3):292-8. doi: 10.1111/ctr.12311. Epub 2014 Jan 30.
8
Quantifying the Race Stratified Impact of Socioeconomics on Graft Outcomes in Kidney Transplant Recipients.量化社会经济因素对肾移植受者移植物结局的种族分层影响。
Transplantation. 2016 Jul;100(7):1550-7. doi: 10.1097/TP.0000000000000931.
9
Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant Recipients.心血管危险因素对黑人肾移植受者移植物结局差异的影响。
Hypertension. 2016 Sep;68(3):715-25. doi: 10.1161/HYPERTENSIONAHA.116.07775. Epub 2016 Jul 11.
10
Twenty years of evolving trends in racial disparities for adult kidney transplant recipients.成年肾移植受者种族差异二十年的演变趋势
Kidney Int. 2016 Oct;90(4):878-87. doi: 10.1016/j.kint.2016.06.029. Epub 2016 Aug 20.

引用本文的文献

1
Characteristics of mismatched eplets affecting de novo donor-specific antibody production and antibody-mediated rejection after kidney transplantation.影响肾移植后新生供体特异性抗体产生及抗体介导排斥反应的错配表位特征。
BMC Nephrol. 2025 Feb 12;26(1):73. doi: 10.1186/s12882-025-04016-3.
2
Advancing kidney transplantation in black patients: a genetics-based and personalized approach under NICE, KDIGO, and ERBP guidelines.推进黑人患者的肾脏移植:基于遗传学和个性化的方法,遵循英国国家卫生与临床优化研究所(NICE)、改善全球肾脏病预后组织(KDIGO)和欧洲肾脏最佳实践组织(ERBP)的指南
Ren Fail. 2024 Dec;46(2):2438856. doi: 10.1080/0886022X.2024.2438856. Epub 2024 Dec 15.
3
Glycemic management and clinical outcomes in underserved minority kidney transplant recipients with type 2 and posttransplantation diabetes: A single-center retrospective study.服务不足的少数族裔 2 型糖尿病和移植后糖尿病肾移植受者的血糖管理和临床结局:一项单中心回顾性研究。
Diabetes Res Clin Pract. 2020 Jul;165:108221. doi: 10.1016/j.diabres.2020.108221. Epub 2020 May 20.
4
A qualitative examination of barriers and solutions to renal transplantation in Malaysia: Key-informants' perspective.马来西亚肾脏移植的障碍和解决方案的定性研究:主要知情人的观点。
PLoS One. 2019 Aug 12;14(8):e0220411. doi: 10.1371/journal.pone.0220411. eCollection 2019.
5
Predicting ideal outcome after pediatric liver transplantation: An exploratory study using machine learning analyses to leverage Studies of Pediatric Liver Transplantation Data.预测小儿肝移植后的理想结局:一项利用机器学习分析对小儿肝移植数据研究进行拓展的探索性研究。
Pediatr Transplant. 2019 Nov;23(7):e13554. doi: 10.1111/petr.13554. Epub 2019 Jul 22.
6
Pharmacist-Led, Technology-Assisted Study to Improve Medication Safety, Cardiovascular Risk Factor Control, and Racial Disparities in Kidney Transplant Recipients.由药剂师主导、技术辅助的研究,旨在改善肾移植受者的用药安全、心血管危险因素控制及种族差异。
J Am Coll Clin Pharm. 2018 Dec;1(2):81-88. doi: 10.1002/jac5.1024. Epub 2018 Jun 21.
7
Xenotransplantation.异种移植
Organogenesis. 2018;14(4):159-162. doi: 10.1080/15476278.2018.1517508. Epub 2018 Sep 25.
8
The impact of time-varying clinical surrogates on disparities in African-American kidney transplant recipients - a retrospective longitudinal cohort study.时间变化的临床替代指标对非裔美国肾移植受者差异的影响——一项回顾性纵向队列研究。
Transpl Int. 2019 Jan;32(1):84-94. doi: 10.1111/tri.13338. Epub 2018 Sep 16.
9
Transplant Center Variability in Disparities for African-American Kidney Transplant Recipients.非裔美国肾移植受者在移植中心差异方面的种族差异
Ann Transplant. 2018 Feb 16;23:119-128. doi: 10.12659/aot.907226.
10
Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation.他克莫司谷浓度变异性与非裔美国肾移植患者的差异
Transplantation. 2017 Dec;101(12):2931-2938. doi: 10.1097/TP.0000000000001840.

本文引用的文献

1
Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation.前瞻性随机对照试验研究兔抗胸腺细胞球蛋白与白细胞介素-2 受体拮抗剂诱导治疗在肾移植中的比较。
Ann Surg. 2014 May;259(5):888-93. doi: 10.1097/SLA.0000000000000496.
2
The impact of cardiovascular disease and risk factor treatment on ethnic disparities in kidney transplant.心血管疾病及危险因素治疗对肾移植中种族差异的影响。
J Cardiovasc Pharmacol Ther. 2013 May;18(3):243-50. doi: 10.1177/1074248412469298. Epub 2012 Dec 20.
3
Inadequacy of cardiovascular risk factor management in chronic kidney transplantation - evidence from the FAVORIT study.慢性肾移植中心血管风险因素管理不足 - FAVORIT 研究的证据。
Clin Transplant. 2012 Jul-Aug;26(4):E438-46. doi: 10.1111/j.1399-0012.2012.01676.x. Epub 2012 Jul 9.
4
Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence.了解肾移植失败的原因:抗体介导的排斥反应和不遵医行为的主导作用。
Am J Transplant. 2012 Feb;12(2):388-99. doi: 10.1111/j.1600-6143.2011.03840.x. Epub 2011 Nov 14.
5
Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis.抗高血压治疗对无高血压人群心血管疾病事件的二级预防作用:一项荟萃分析。
JAMA. 2011 Mar 2;305(9):913-22. doi: 10.1001/jama.2011.250.
6
Cardiovascular disease medications after renal transplantation: results from the Patient Outcomes in Renal Transplantation study.肾移植后心血管疾病药物治疗:来自肾移植患者结局研究的结果。
Transplantation. 2011 Mar 15;91(5):542-51. doi: 10.1097/TP.0b013e31820437bd.
7
The relative risk of overall graft loss and acute rejection among African American renal transplant recipients is attenuated with advancing age.在非裔美国肾移植受者中,随着年龄的增长,整体移植物丢失和急性排斥反应的相对风险会降低。
Clin Transplant. 2011 Sep-Oct;25(5):721-30. doi: 10.1111/j.1399-0012.2010.01343.x. Epub 2010 Oct 22.
8
Treatment of polyomavirus infection in kidney transplant recipients: a systematic review.肾移植受者多瘤病毒感染的治疗:系统评价。
Transplantation. 2010 May 15;89(9):1057-70. doi: 10.1097/TP.0b013e3181d0e15e.
9
African American kidney transplantation survival: the ability of immunosuppression to balance the inherent pre- and post-transplant risk factors.非裔美国人肾移植存活率:免疫抑制的能力平衡固有移植前和移植后风险因素。
Drugs. 2009 Oct 22;69(15):2045-62. doi: 10.2165/11318570-000000000-00000.
10
Systematic review: glucose control and cardiovascular disease in type 2 diabetes.系统评价:2型糖尿病患者的血糖控制与心血管疾病
Ann Intern Med. 2009 Sep 15;151(6):394-403. doi: 10.7326/0003-4819-151-6-200909150-00137. Epub 2009 Jul 20.